Insulin Regimen Adjustment for Diabetic Patients with Elevated HbA1c

Current Situation Assessment

The American Diabetes Association and the European Association for the Study of Diabetes recommend that patients with an HbA1c of 53.5 mmol/mol (7.0%) or higher should have their insulin regimen adjusted to achieve better glycemic control 1, 2
NovoMix (70/30 aspart mix) may not adequately cover postprandial glucose excursions throughout the day, as it contains both rapid-acting and intermediate-acting insulin components 1, 3
The current regimen of 38IU AM and 18IU PM may not be providing sufficient coverage for all meals, highlighting the need for adjustment 4

The American College of Endocrinology recommends assessing blood glucose patterns throughout the day using self-monitoring of blood glucose (SMBG) to identify specific times of hyperglycemia 1, 2
Determining if fasting blood glucose levels are at target or if postprandial excursions are the primary issue is crucial for adjusting the insulin regimen 5
Adding a rapid-acting insulin analog (insulin aspart, lispro, or glulisine) before meals can better control postprandial glucose excursions, with a starting dose of 4 units or 10% of the total daily insulin dose 1, 3, 2, 5
The American Diabetes Association recommends adjusting the NovoMix doses if adding mealtime insulin, potentially reducing the morning dose by 10% to avoid hypoglycemia 2, 5

The European Association for the Study of Diabetes recommends increasing the prandial insulin dose by 1-2 units or 10-15% twice weekly based on postprandial glucose readings 2, 5
Adjusting both basal and prandial insulin components based on SMBG results is essential for optimizing glycemic control 1
For any hypoglycemic episodes, determining the cause and reducing the corresponding insulin dose by 10-20% is recommended 2, 5

The American College of Endocrinology states that insulin therapy should not be delayed in patients not achieving glycemic goals, with a B rating 1, 3
Timely dose titration is crucial for optimizing glycemic control, according to the American Diabetes Association 1, 3
When adding prandial insulin to a premixed insulin regimen, considering the risk of hypoglycemia and adjusting doses accordingly is essential, as recommended by the European Association for the Study of Diabetes 2, 5
Patient education on insulin administration, SMBG, and hypoglycemia management is essential, as emphasized by the American Diabetes Association 2, 5